Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Literature
1.
Singh U, Vishwanath A, Verma PK, Singh NK, Shukla RC, Singh S, Singh S, Sonkar GK (2010) Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis? Rheumatol Int. doi: 10.1007/s00296-009-1338-0
2.
Liao KP, Batra KL, Chibnik L, Schur PH, Costenbader KH (2008) Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis 67:1557–1561PubMedCrossRef
3.
Narain S, Kosboth M, Hahn P (2006) Autoantibody testing in rheumatoid arthritis. In: Detrick B, Hamilton RG, Folds JD (eds) Manual of molecular and clinical laboratory immunology, 7th edn. ASM Press, Washington DC, pp 1033–1045
4.
Emad Y, Shehata M, Ragab Y, Saad A, Hamza H, Abou-Zeid A (2010) Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis. Mod Rheumatol. doi: 10.​1007/​s10165-010-0286-6
5.
Kim DA, Jearn LH, Kim TY (2007) Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis. J Rheumatol 34:1944–1945PubMed
Metadata
Title
RF vs. anti-CCP: competitor or companion?
Publication date
01-09-2011
Published in
Rheumatology International / Issue 9/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1585-0

Other articles of this Issue 9/2011

Rheumatology International 9/2011 Go to the issue

Original Article

Systemic lupus erythematosus pregnancies: the Sarawak experience and review of lupus pregnancies in Asia

Short Communication

Fatal rhabdomyolysis in systemic lupus erythematosus

Original Article

Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis

Original Article

Comparison the efficacy of phonophoresis and ultrasound therapy in myofascial pain syndrome

Short Communication

Severe headache complicated by vertical atlantoaxial subluxation in diffuse systemic sclerosis with crowned dens pattern calcification

Original Article

The vasoactive intestinal polypeptide (VIP) levels at the patients with ankylosing spondylitis and its association with inflammation markers
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits